Skip to content

Incentives for Adherence in Adolescent Asthma

Incentives for Medication Adherence in Adolescents With Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03515499
Enrollment
52
Registered
2018-05-03
Start date
2018-07-06
Completion date
2020-02-05
Last updated
2020-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Asthma in Children

Keywords

Adherence, Incentives

Brief summary

Financial incentives have been suggested as a possible means for increasing adherence to asthma medications. This study will evaluate an incentive strategy (daily small reward for adherence) in maintaining high levels of adherence as tracked by adherence sensors in adolescents with asthma.

Detailed description

Two groups will be enrolled. The control group will have mediation monitoring sensors placed on their controller inhalers. The treatment group will also have the monitoring sensors placed on their medications, however they will be paid up to $1 per day for perfect adherence for 3 months. Both groups will be monitored for 4 months. 10 subjects will be chosen from each group to complete semi-structured phone interviews

Interventions

BEHAVIORALIncentives

Subjects in the treatment arm will be paid up to $1 per day over 3 months for perfect medication adherence. Adherence rates will then be compared between the 2 groups.

BEHAVIORALMedication device monitoring and reminders

Bluetooth enabled sensor device for medication reminders, as well as mobile app to track medication use.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* physician diagnosed asthma * on at least one inhaled controller medication

Exclusion criteria

* language other than English or Spanish (these are the only languages supported by the adherence monitoring application) * other severe chronic lung disease including tracheostomy/ventilator dependence, interstitial lung disease or cystic fibrosis, or significant developmental delay.

Design outcomes

Primary

MeasureTime frameDescription
Change in adherence ratesDaily for 12 weeksThis Outcome will measure the difference in adherence at the end of the study period between the 2 groups as measured by the adherence devices (calculated as percent adherence per week over the 12 week study period).

Secondary

MeasureTime frameDescription
Changes in Qualitative outcomes - BarriersAfter 3 months of monitoringQualitative methodology will be used to evaluate patient attitudes towards the incentive program, as well as barriers of adherence, using semi-structured interviews. The investigators will obtain information on attitudes regarding barriers to medication adherence
Changes in Qualitative outcomes - FacilitatorsAfter 3 months of monitoringQualitative methodology will be used to evaluate patient attitudes towards the incentive program, as well as facilitators of adherence, using semi-structured interviews. The investigators will obtain information on attitudes regarding facilitators to adequate medication adherence.
Changes in Qualitative outcomes - IncentivesAfter 3 months of monitoringQualitatively assessed feelings regarding incentives Qualitative methodology will be used to evaluate patient feelings towards the incentive program.The investigators will obtain information on incentives to adequate medication adherence.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026